Insider · CIK 0001256126
Peter Mueller
Files at BTAIQ (BioXcel Therapeutics, Inc.). First filing -, latest -.
In brief
Peter Mueller files SEC Form 4 as director at BTAIQ (BioXcel Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Peter Mueller has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | BTAIQ BioXcel Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +17,000 | $0.00 | $0 | 17,000 | Jan 12, 2026 |
Questions about Peter Mueller
Answered from the filings on this page, as of the latest one.
Is Peter Mueller buying or selling?
Peter Mueller has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Peter Mueller's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Peter Mueller has 0.
Where does Peter Mueller file Form 4?
Peter Mueller has filed Form 4 at BTAIQ (BioXcel Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.